Phase 3 human trial for Covaxin starts at SRM Hospital

0
78
ViroVax's adjuvant to enhance Bharat Biotech's Covaxin immunity
ViroVax's adjuvant to enhance Bharat Biotech's Covaxin immunity

The SRM Medical College Hospital and Research Centre here on Monday announced the launch of the third phase of human trials for Covaxin – a vaccine for Covid-19 developed by Bharat Biotech.

In a statement issued here, the SRM Medical College Hospital said the vaccine in the third phase will be tested on about 1,000-1,500 volunteers.

During the first phase, the vaccine was tested on 30 volunteers, and in the second phase, on over 150 persons and their health is being monitored, it added.

LEAVE A REPLY

Please enter your comment!
Please enter your name here